An Investigation of TAS-119 Monotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A Phase 1, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of TAS-119 in Patients with Advanced Solid Tumors.
Epistemonikos ID: aebaab7a9f00da6756f8f182e2716f19dc329f43
First added on: May 12, 2024